• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔卫生不良与 MRONJ 之间的潜在关系:一项观察性回顾性研究。

Potential Relationship between Poor Oral Hygiene and MRONJ: An Observational Retrospective Study.

机构信息

Complex Unit of Odontostomatology, Interdisciplinary Department of Medicine, University Aldo Moro of Bari, 70121 Bari, Italy.

Department of Medical, Oral and Biotechnological Sciences, University Gabriele d'Annunzio, 66100 Chieti, Italy.

出版信息

Int J Environ Res Public Health. 2023 Apr 5;20(7):5402. doi: 10.3390/ijerph20075402.

DOI:10.3390/ijerph20075402
PMID:37048016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10094150/
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a drug-related side effect linked but not limited to antiresorptive and antiangiogenic molecules. It recognizes several triggers in dental procedures, such as surgery, endodontic treatments, and root planing, but also prosthesis decubitus or with a spontaneous onset. Although there are many reports about the onset of this pathology, oral hygiene status is mainly described as a consequence of MRONJ. Not so much is known about the oral hygiene situation as a concurrent factor in the pathogenesis of severe stages and about non-surgical periodontal therapy in patients affected by MRONJ. Actually, clear instructions for non-surgical periodontal therapy are poor in the literature. The primary outcome of the present study is to evaluate the oral hygiene status in MRONJ patients. In addition, a secondary outcome is to review the factor of poor oral hygiene as a cause or worsening aspect for MRONJ. A total of 45 subjects (19 males and 26 females) with a mean age of 59 ± 12 were enrolled. The Pearson correlation coefficient showed no significant results for the variable of the Simplified Oral Hygiene Index (OHI-S) and the American Association of Oral and Maxillofacial Surgeons (AAOMS) stage, although the majority of patients showed poor oral hygiene with an OHI-S average of 3.39 ± 1.83. As stated by the last AAOMS position paper, poor plaque control is related to a worsened MRONJ stage. The relation between the lack of oral hygiene and MRONJ onset is still unclear.

摘要

药物相关性颌骨坏死(MRONJ)是一种与药物相关的副作用,不仅与抗吸收和抗血管生成分子有关。它认识到几种在牙科手术中的触发因素,如手术、根管治疗和根面平整,但也与义齿卧床或自发性发病有关。尽管有许多关于这种病理学发病的报道,但口腔卫生状况主要被描述为 MRONJ 的后果。关于口腔卫生状况作为严重阶段发病机制的并发因素以及 MRONJ 患者非手术牙周治疗的了解并不多。实际上,文献中对非手术牙周治疗的明确指导很差。本研究的主要结果是评估 MRONJ 患者的口腔卫生状况。此外,次要结果是回顾不良口腔卫生状况作为 MRONJ 的原因或恶化方面的因素。共纳入 45 名受试者(19 名男性和 26 名女性),平均年龄为 59±12 岁。Pearson 相关系数显示简化口腔卫生指数(OHI-S)和美国口腔颌面外科学会(AAOMS)分期的变量之间没有显著结果,尽管大多数患者的口腔卫生状况较差,OHI-S 平均为 3.39±1.83。正如最后一份 AAOMS 立场文件所述,不良的菌斑控制与 MRONJ 分期恶化有关。口腔卫生不良与 MRONJ 发病之间的关系尚不清楚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/068d1788c565/ijerph-20-05402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/3e1280c5a40c/ijerph-20-05402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/8a71f9fd22ee/ijerph-20-05402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/068d1788c565/ijerph-20-05402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/3e1280c5a40c/ijerph-20-05402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/8a71f9fd22ee/ijerph-20-05402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10094150/068d1788c565/ijerph-20-05402-g003.jpg

相似文献

1
Potential Relationship between Poor Oral Hygiene and MRONJ: An Observational Retrospective Study.口腔卫生不良与 MRONJ 之间的潜在关系:一项观察性回顾性研究。
Int J Environ Res Public Health. 2023 Apr 5;20(7):5402. doi: 10.3390/ijerph20075402.
2
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死:双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
3
[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].[关于药物性颌骨坏死(MRONJ)的立场文件]
Wien Med Wochenschr. 2016 Feb;166(1-2):68-74. doi: 10.1007/s10354-016-0437-2.
4
Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.抗吸收剂治疗骨质疏松症患者药物相关性颌骨坏死的手术治疗。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Mar;164(1):100-107. doi: 10.5507/bp.2018.081. Epub 2019 Jan 10.
5
Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.拔牙后骨质疏松症患者药物相关性颌骨坏死(MRONJ)的发生率及相关危险因素。一项为期 12 个月的观察性队列研究。
J Stomatol Oral Maxillofac Surg. 2022 Nov;123(6):616-621. doi: 10.1016/j.jormas.2022.03.020. Epub 2022 May 21.
6
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.美国口腔颌面外科学会关于药物相关性颌骨坏死的立场文件-2022 更新。
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
7
Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.骨质疏松症患者接受口服双膦酸盐治疗后发生药物相关性颌骨骨坏死(MRONJ)病变的保守性外科治疗:24 个月随访。
J Craniomaxillofac Surg. 2018 Jul;46(7):1153-1158. doi: 10.1016/j.jcms.2018.05.003. Epub 2018 May 9.
8
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究,探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素:原发伤口闭合和药物暂停真的能预防 MRONJ 吗?
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
9
A Study of Oral Health Parameters and the Properties and Composition of Saliva in Oncological Patients with and without Medication-Related Osteonecrosis of the Jaw Who Take Bisphosphonates.一项关于接受双磷酸盐治疗的伴或不伴药物相关性颌骨坏死的肿瘤患者的口腔健康参数以及唾液特性和成分的研究。
Medicina (Kaunas). 2023 Jun 2;59(6):1073. doi: 10.3390/medicina59061073.
10
The Prevention of Medication-related Osteonecrosis of the Jaw.预防药物相关性颌骨坏死。
Dtsch Arztebl Int. 2017 Feb 3;114(5):63-69. doi: 10.3238/arztebl.2017.0063.

引用本文的文献

1
Prevalence of Free Flap Failure in Patients Undergoing Reconstruction for Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis.接受颌骨药物相关性骨坏死重建患者游离皮瓣失败的患病率:一项系统评价和荟萃分析。
Clin Pract. 2025 Aug 14;15(8):151. doi: 10.3390/clinpract15080151.
2
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
3
Impact of Chemotherapy Alone and in Combination with Immunotherapy on Oral Microbiota in Cancer Patients-A Pilot Study.

本文引用的文献

1
Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.低水平激光疗法通过 IL-1RA 介导的原发性牙龈创面愈合预防药物相关性颌骨样骨坏死性病变。
BMC Oral Health. 2023 Jan 10;23(1):14. doi: 10.1186/s12903-022-02678-1.
2
Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients.肿瘤患者因牙髓治疗失败引起的药物相关性颌骨坏死。
Oral Dis. 2023 Oct;29(7):2799-2805. doi: 10.1111/odi.14449. Epub 2022 Dec 15.
3
Minimizing MRONJ after Tooth Extraction in Cancer Patients Receiving Bone-Modifying Agents.
单纯化疗及联合免疫疗法对癌症患者口腔微生物群的影响——一项初步研究
Microorganisms. 2025 Jul 3;13(7):1565. doi: 10.3390/microorganisms13071565.
4
Photobiomodulation in Medication-Related Osteonecrosis of the Jaw: Outcomes in Stage I and Its Adjunctive Role in Advanced Cases.光生物调节在药物相关性颌骨坏死中的应用:I期治疗效果及其在晚期病例中的辅助作用
Biomedicines. 2025 Apr 25;13(5):1042. doi: 10.3390/biomedicines13051042.
5
The Role of Cone Beam Computed Tomography (CBCT) in the Diagnosis and Clinical Management of Medication-Related Osteonecrosis of the Jaw (MRONJ).锥形束计算机断层扫描(CBCT)在颌骨药物相关性骨坏死(MRONJ)诊断及临床管理中的作用
Diagnostics (Basel). 2024 Aug 6;14(16):1700. doi: 10.3390/diagnostics14161700.
6
Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF-12 and OHIP-14 Questionnaires.MRONJ患者手术治疗后生活质量的改善:使用SF - 12和OHIP - 14问卷的前瞻性分析
Int J Dent. 2024 Apr 30;2024:4435791. doi: 10.1155/2024/4435791. eCollection 2024.
7
Adjunctive Plasma Rich in Growth Factors in the Treatment of Osteomyelitis and Large Odontogenic Cysts Prior to Successful Implant Rehabilitation: Case Report.富含生长因子的血浆在成功进行种植修复前治疗骨髓炎和大型牙源性囊肿中的辅助应用:病例报告
Dent J (Basel). 2023 Jul 31;11(8):184. doi: 10.3390/dj11080184.
8
Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case-Control Pilot Study.药物性颌骨坏死患者的口腔健康相关生活质量与心理健康损害:一项病例对照试点研究。
Dent J (Basel). 2023 Jun 7;11(6):147. doi: 10.3390/dj11060147.
在接受骨改良药物治疗的癌症患者拔牙后将下颌骨坏死风险降至最低
J Clin Med. 2022 Mar 25;11(7):1807. doi: 10.3390/jcm11071807.
4
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.美国口腔颌面外科学会关于药物相关性颌骨坏死的立场文件-2022 更新。
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
5
Oral hygiene and oral microbiota in children and young people with neurological impairment and oropharyngeal dysphagia.儿童和青少年神经功能障碍及口咽性吞咽困难患者的口腔卫生和口腔微生物群。
Sci Rep. 2021 Sep 10;11(1):18090. doi: 10.1038/s41598-021-97425-x.
6
Medication-Related Osteonecrosis of the Jaw and Low-Level Laser Therapy as Adjuvant Treatment: A Case Report.颌骨药物相关性骨坏死与低强度激光治疗作为辅助治疗:一例报告
J Lasers Med Sci. 2020 Fall;11(4):497-499. doi: 10.34172/jlms.2020.78. Epub 2020 Oct 3.
7
Relationship between oral condition and risk factors for jaw osteonecrosis in patients with hip fractures.口腔状况与髋部骨折患者颌骨坏死风险因素的关系。
J Med Invest. 2020;67(3.4):328-331. doi: 10.2152/jmi.67.328.
8
Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.药物相关性颌骨骨坏死的发病机制与多学科管理。
Int J Oral Sci. 2020 Oct 21;12(1):30. doi: 10.1038/s41368-020-00093-2.
9
Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy.对有发生颌骨药物相关性骨坏死(MRONJ)风险患者的认知——一项一级预防策略。
Saudi Pharm J. 2020 Jun;28(6):771-778. doi: 10.1016/j.jsps.2020.05.004. Epub 2020 May 15.
10
Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis.激光手术在颌骨药物相关性骨坏死治疗中的应用:一项荟萃分析。
Oral Maxillofac Surg. 2020 Jun;24(2):133-144. doi: 10.1007/s10006-020-00831-0. Epub 2020 Feb 13.